Notably, the matricellular proteins decorin (DCN) [43,46] and thrombospondin 1 (TSP1) are arising as important regulators of TGF-β1 activity in RDEB patients and could represent relevant targets for innovative therapeutic approaches to counteract fibrosis progression [47]. Here, TGFB1 is linked to recessive dystrophic epidermolysis bullosa.